期刊文献+

磁性壳聚糖-5-氟尿嘧啶纳米粒的制备及体外释药性能 被引量:11

Preparation and in Vitro Release of Magnetic Citosan-5-Fluorouracil Nanoparticles
下载PDF
导出
摘要 采用交联-聚合法在超声波的作用下,制备了磁性壳聚糖-5-氟尿嘧啶纳米粒(M CN-Fu)。透射电子显微镜(TEM)和红外光谱(IR)等分析结果表明,M CN-Fu粒子外形规整,分散性好,粒径主要在50 nm^60 nm之间。紫外-可见光谱分析结果表明,M CN-Fu的载药量为21.3%,在磷酸盐缓冲溶液(pH=7.2)中,30 h的累积释药率为67.6%,具有良好缓释性能,并具有良好磁响应性能。 In order to prepare the targeting drug-loaded system, magnetic chitosan-5-Fu nanoparticles (MCN-Fu) were prepared by using 5-Fu as a model drug, Fe3O4nanoparticles as the core and glutaraldehyde as cross-linking agent under ultrasonic treatment. TEM images show that MCN-Fu are spherical shape with diameters ranged from 50 nm- 60 nm. The IR results indicate there is a strong molecular interaction between 5-Fu and chitosan. The drug content, in vitro release and magnetic properties of MCN-Fu were investigated by UV-vis spectrum. The results indicate that the drug content is 21.3%, and accumulative release percentage in phosphate buffer (pH=7.2) solution is 67.6% in 30 h , the drug release rate is found decreased and they can in some degree reduce initial burst. MCN-Fu have good magnetic properties and target effect.
出处 《高分子材料科学与工程》 EI CAS CSCD 北大核心 2007年第1期189-191,195,共4页 Polymer Materials Science & Engineering
基金 国家863项目(2001AA218011) 湖南省自然科学基金(06JJ20038) 长沙理工大学科研基金(04xxrc031) 湖南省青年骨干教师培养基金
关键词 磁性 壳聚糖 氟尿嘧啶 纳米粒 药物缓释剂 magnetic, chitosan fluorouracil nanoparticle drug releasing
  • 相关文献

参考文献8

  • 1Wasterack C, Bettina H. Pharmaze, 1987, 12(2): 73.
  • 2Matcucci F, Lefoulon F. Drug Discovery Today, 2004,9(5): 219-228.
  • 3Voltairas P A, Fotiadis D I, Michalis L K. Journal of Biomechanics, 2002,35: 813-821.
  • 4Chiriac H, Moga A E, lacob G, et al. Journal of Magnetism and Magnetic Materials, 2005, 293: 28-32.
  • 5Sinha V R, Singla A K, Wadhawan S, et al. International journal of Pharmaceutics, 2004, 274: 1- 33.
  • 6Jiang D S, Long S Y, Huang J, et al. Biochemical Engineering Journal, 2005, 25: 15-23.
  • 7李和平,阮建明,黄伯云,王亚东.磁性壳聚糖纳米粒子的制备及表征[J].中南大学学报(自然科学版),2004,35(2):175-179. 被引量:9
  • 8何强芳,李国明,巫海珍,卢志敏,李良.5-氟尿嘧啶壳聚糖微球的制备及其释药性能[J].应用化学,2004,21(2):192-196. 被引量:48

二级参考文献17

  • 1关丽 李国明 黄晓燕.J South China Normal Unv(Nat SciEdn)(华南师范大学学报(自然科学版))[J],2001,2(1):79-79.
  • 2王亚敏 石庭森 蒲永林.Acta Pharm Sin(药学学报)[J],1996,31(4):300-300.
  • 3Kappen P J K,Schuitemaker H,Van't veer L T,et al.Cis-Diammine-dicholoroplatinum(Ⅱ): resistant sublines derved from two human ovarinan tumor cell lines [J].Cancer Res,1988.48: 3355-3361.
  • 4Jordan A,Scholz R,Maier-Hauff K,et al.Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia [J].Journal of Magnetism and Magnetic Materials,2001,225:118-126.
  • 5Denkbas E B,Kilicay E,Birlikseven C,et al.Magnetic chitosan microspheres: preparation and characterization[J].Reactive & Functional Polymers,2002,50(3):225-232.
  • 6陈盛 罗志敏 马秀玲.磁性壳聚糖微球[J].化学通报,2003,66(26):1-6.
  • 7Banerjee T,Mitra S,Singh A K,et al.Preparation,characterization and biodistribution of ultrafine chitosan nanoparticles[J].International Journal of Pharmaceutics,2002,243(1-2):93-105.
  • 8Gupta K C,Ravi Kumar M N V.Drug release behavior of beads and microgranules of chitosan [J].Biomaterials,2000,21(11):1 115-1 119.
  • 9Hu Y,Jiang X,Ding Y,et al.Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles[J].Biomaterials,2002,23:3 193-3 201.
  • 10Gupta P K,Hung C T,Tao N S.Ultrastructural disposition of adriamycin-associated magnetic albumin microspheres in rats[J].J Pharm Sci,1989,78(4):290-294.

共引文献55

同被引文献147

引证文献11

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部